COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Evaluation of Alveolar Augmentation Using Tunneling Surgical Technique

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03498573
Recruitment Status : Unknown
Verified April 2018 by Hussien Amer Elkady, Cairo University.
Recruitment status was:  Not yet recruiting
First Posted : April 13, 2018
Last Update Posted : April 13, 2018
Information provided by (Responsible Party):
Hussien Amer Elkady, Cairo University

Brief Summary:
patients suffering from anterior maxillary horizontal bone defect the alveolar ridge will be augmented by minimally invasive tunneling technique utilizing MPM as bone graft and patients followed up for 14 weeks .

Condition or disease Intervention/treatment Phase
Bone Atrophy Other: tunneling surgical technique Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 10 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Evaluation of Minimally Invasive Alveolar Augmentation Procedure of Anterior Maxillary Ridge Using Tunneling Surgical Technique
Estimated Study Start Date : May 1, 2018
Estimated Primary Completion Date : July 2018
Estimated Study Completion Date : April 2019

Arm Intervention/treatment
Experimental: tunneling surgical technique Other: tunneling surgical technique
sticky bone prepared by centrifuge patient blood and mixing with xinograft
Other Name: mpm

Primary Outcome Measures :
  1. bone formation [ Time Frame: 14 weeks ]
    bone formation assessed by cone beam ct

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years to 60 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Patients' age range from 18-60 years.
  • Patients with horizontal bone defect in anterior maxillary area.
  • Patients should be free from any systemic disease that may affect normal healing of bone and predictable outcome.

Exclusion Criteria:

• Patients with systemic diseases as history of radiation therapy or chemotherapy, hematological disorders and autoimmune diseases (may affect normal healing).

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT03498573

Layout table for location contacts
Contact: hussien amer elkady, B.D.S 01141178095
Contact: tarek elghareeb

Sponsors and Collaborators
Hussien Amer Elkady

Layout table for additonal information
Responsible Party: Hussien Amer Elkady, dentist, Cairo University Identifier: NCT03498573    
Other Study ID Numbers: 29004052103937
First Posted: April 13, 2018    Key Record Dates
Last Update Posted: April 13, 2018
Last Verified: April 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Pathological Conditions, Anatomical